Protein Biomarker Discovery Using Human Blood Plasma Microparticles

Area of Science:

• Biochemistry and Molecular Biology
• Biomarker Discovery
• Proteomics

Background:

• Cells release microparticles (MPs), which are plasma membrane-derived vesicles found in body fluids.
• MPs contain cell-type and disease-specific proteins, making them potential biomarkers for various conditions.
• Advancements in mass spectrometry have expanded knowledge of plasma MP (PMP) protein composition, aiding biomarker discovery.

Purpose of the Study:

• To address the limitations in standardized PMP isolation protocols for clinical applications.
• To present a detailed and robust protocol for isolating PMPs from human blood plasma.
• To enable accurate proteome analysis of isolated PMPs for biomarker identification.

Main Methods:

• Isolation of PMPs from human blood plasma using ultracentrifugation.
• Label-free quantitative proteome analysis of the isolated PMPs.
• Detailed description of the developed PMP isolation protocol.

Main Results:

• A robust protocol for PMP isolation from human plasma was successfully established.
• The protocol enables subsequent quantitative proteome analysis of PMPs.
• This method facilitates the exploration of PMPs as diagnostic biomarkers.

Conclusions:

• The developed ultracentrifugation-based protocol offers a standardized approach for PMP isolation.
• This standardized method is crucial for the reliable discovery and validation of PMP biomarkers.
• Improved PMP isolation protocols are essential for advancing their clinical utility in disease diagnostics.